Gonorrhea testing, morbidity, and reporting using an integrated sexually transmitted disease registry in Indiana: 2004-2016
dc.contributor.author | Ojo, Opeyemi C. | |
dc.contributor.author | Arno, Janet N. | |
dc.contributor.author | Tao, Guoyu | |
dc.contributor.author | Patel, Chirag G. | |
dc.contributor.author | Zhang, Zuoyi | |
dc.contributor.author | Wang, Jane | |
dc.contributor.author | Holderman, Justin | |
dc.contributor.author | Dixon, Brian E. | |
dc.contributor.department | Medicine, School of Medicine | en_US |
dc.date.accessioned | 2023-04-25T11:09:29Z | |
dc.date.available | 2023-04-25T11:09:29Z | |
dc.date.issued | 2021-01 | |
dc.description.abstract | Background: Surveillance of gonorrhea (GC), the second most common notifiable disease in the United States, depends on case reports. Population-level data that contain the number of individuals tested in addition to morbidity are lacking. Methods: We performed a cross-sectional analysis of data obtained from individuals tested for GC recorded in a STD registry. Descriptive statistics were performed, and a Poisson generalized linear model was used to evaluate the number of individuals tested for GC and the positivity rate. GC cases from a subset of the registry was compared to CDC to determine the completeness of the registry. Results: A total of 1,870,811 GC tests were linked to 627,870 unique individuals. Individuals tested for GC increased from 54,334 in 2004 to 269,701 in 2016; likewise, GC cases increased from 2,039 to 5,997. However, positivity rate decreased from 3.75% in 2004 to 2.22% in 2016. The difference in the number of GC cases captured by the registry and those reported to the CDC were not statistically significant (P= 0.0665). Conclusions: Population-level data from a STD registry combining electronic medical records and public health case data may inform STD control efforts. In Indiana, increased testing rates appeared to correlate with increased GC morbidity. | en_US |
dc.eprint.version | Author's manuscript | en_US |
dc.identifier.citation | Ojo OC, Arno JN, Tao G, et al. Gonorrhea testing, morbidity, and reporting using an integrated sexually transmitted disease registry in Indiana: 2004-2016. Int J STD AIDS. 2021;32(1):30-37. doi:10.1177/0956462420953718 | en_US |
dc.identifier.uri | https://hdl.handle.net/1805/32565 | |
dc.language.iso | en_US | en_US |
dc.publisher | Sage | en_US |
dc.relation.isversionof | 10.1177/0956462420953718 | en_US |
dc.relation.journal | International Journal of STD & AIDS | en_US |
dc.rights | Publisher Policy | en_US |
dc.source | PMC | en_US |
dc.subject | Gonorrhea | en_US |
dc.subject | Screening | en_US |
dc.subject | Epidemiology | en_US |
dc.subject | Diagnosis | en_US |
dc.title | Gonorrhea testing, morbidity, and reporting using an integrated sexually transmitted disease registry in Indiana: 2004-2016 | en_US |
dc.type | Article | en_US |